Abstract:Background: Previous studies have revealed higher mortality rates in patients of severe influenza coinfected with invasive pulmonary aspergillosis (IPA) than in those without the coinfection; nonetheless, the clinical outcome of IPA in critically ill patients without influenza remains unclear. Patients and methods: This retrospective study was conducted in three institutes. From 2016-2018, all adult patients diagnosed with IPA in the intensive care units (ICUs) were identified. The logistic regression was used to identify the potential risk factors associated with in-hospital mortality in patients with non-influenza IPA. The stratified analysis of IPA patients with and without antifungal therapy was also performed. The final model was established using a forward approach, selecting variables with p-values less than 0.05. Results: Ninety patients were included during the study period, and 63 (70%) were men. The most common comorbidity was diabetes mellitus (n = 24, 27%), followed by solid cancers (n = 22, 24%). Antifungal therapy was administered to 50 (56%) patients, mostly voriconazole (n = 44). The in-hospital mortality rate was 49% (n = 44). Univariate analysis revealed that the risk factors for mortality included daily steroid dose, APACHE II score, SOFA score, C-reactive protein (CRP) level, carbapenem use, antifungal therapy, and caspofungin use. Multiple regression analysis identified four independent risk factors for mortality: age (Odds ratio [OR], 1.052, p = 0.013), daily steroid dose (OR, 1.057, p = 0.002), APACHE II score (OR, 1.094, p = 0.012), and CRP level (OR, 1.007, p = 0.008). Furthermore, the multivariable analysis identified that more physicians would initiate antifungal therapy for patients with prolonged steroid use (p = 0.001), lower white blood cell count (p = 0.021), and higher SOFA score (p = 0.048). Thus, under the selection bias, the independent risk factors for mortality in the antifungal treatment subgroup were daily steroid dose (OR, 1.046, p = 0.001) and CRP (OR, 1.006, p = 0.018), whereas the independent risk factor for mortality in the untreated group became APACHE II score (OR, 1.232, p = 0.007). Conclusions: Patients with IPA had a substantially high mortality. Overall, age, steroid use, APACHE II score, and CRP level were identified as the independent risk factors for mortality in patients in the ICU.

Invasive Pulmonary Aspergillosis in Patients with HBV-Related Acute on Chronic Liver Failure

Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.

Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study

Epidemiology of Invasive Pulmonary Aspergillosis in Patients with Liver Failure: Clinical Presentation, Risk Factors, and Outcomes.

Clinical Findings in 19 Cases of Invasive Pulmonary Aspergillosis with Liver Cirrhosis

Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options

Hospital-acquired Invasive Pulmonary Aspergillosis in Patients with Hepatic Failure

The 90-Day Survival Threshold: A Pivotal Determinant of Long-Term Prognosis in HBV-ACLF Patients - Insights from a Prospective Longitudinal Cohort Study.

Prognostic factors and outcomes of invasive pulmonary aspergillosis, a retrospective hospital-based study

Invasive Pulmonary Aspergillosis in Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis.

A clinical study of 49 cases of invasive pulmonary aspergillosis]

Characteristics and outcomes for pulmonary aspergillosis in critically ill patients without influenza: A 3-year retrospective study

Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis

Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study

Invasive Pulmonary Aspergillosis in Patients with Chronic Obstructive Pulmonary Disease: a Case Report and Review of the Literature

Analysis of risk factors of mortality in interstitial pneumonia patients with invasive pulmonary aspergillosis

Clinical analysis of 21 cases of invasive pulmonary aspergillosis

Diagnosis of Invasive Pulmonary Aspergillosis in the Intensive Care Unit: What We Should Concern and How to Do Better

Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan

A clinical studv of 49 cases of invasive pulmonary aspergillosis

Virulence capacity of different Aspergillus species from invasive pulmonary aspergillosis